A significant association of the CTLA4 gene variants with the risk of autoimmune Graves’ disease in ethnic Kashmiri population

• Published in: Cellular immunology Vol. 347; p. 103995
• Main Authors: Shehjar, Faheem, Dil-Afroze, Misgar, Riaz A, Malik, Sajad A, Laway, Bashir A
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-01-2020
• Subjects: CTLA4; Graves’ disease; Restriction fragment length polymorphism; Single nucleotide polymorphism; CTLA4; Restriction fragment length polymorphism; Single nucleotide polymorphism; Graves’ disease
• ISSN: 0008-8749; 1090-2163
• DOI: 10.1016/j.cellimm.2019.103995

•It is a first study of its kind from North India (Kashmir).•135 confirmed Graves’ disease cases and 150 age and gender matched controls were screened for four CTLA4 SNPs.•CTLA-4 + 49 A/G and CT60 A/G SNPs have a significant association with the risk of GD development.
Graves’ disease (GD) is the commonest cause of hyperthyroidism in populations with adequate iodine intake. It results from an abnormality in the immune system, which produces unique antibodies causing over production of thyroid hormones and glandular hyperplasia in individuals with genetic susceptibility. The Cytotoxic Lymphocyte Associated Antigen-4 (CTLA4) gene product serves the important function of immunomodulation, thereby helping in maintenance of peripheral self-tolerance. Studies on the association of the CTLA4 SNPs with GD have shown variations in the results from different populations. Since no such study has been carried out in ethnic Kashmiri population, we aimed to study a possible association of the CTLA4 SNPs (+49 A/G, −318C/T, CT 60 A/G and −1661 A/G) with GD. A total of 285 individuals (135 patients with GD and 150 healthy individuals) were genotyped using PCR-RFLP method and the results showed statistically significant differences in genotypic and allelic frequencies of cases and controls for + 49 A/G SNP (p=<0.001; OR = 5.14; CI = 2.17–12.19) and CT 60 A/G SNP (p = < 0.001; OR = 6.9; CI = 2.8–16.6), while −318C/T and −1661 A/G SNPs showed no significant association. We also studied the mRNA expression of the CTLA4 in patients with GD and healthy individuals by Real-Time PCR and found a decreased expression of the CTLA4 mRNA in PBMCs of patients with GD as compared to healthy controls with a −3.71-fold change. We conclude that the CTLA4 + 49 A/G and CT 60 A/G SNPs have a significant association with the risk of GD development in Kashmiri population and CTLA4 mRNA expression is significantly decreased in GD.